🇺🇸 FDA
Patent

US 7119105

Methods for treating neurodegenerative disorders using aspartyl protease inhibitors

granted A61KA61K31/36A61K31/4035

Quick answer

US patent 7119105 (Methods for treating neurodegenerative disorders using aspartyl protease inhibitors) held by The Regents of the University of California expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61K, A61K31/36, A61K31/4035, A61K31/423, A61K31/445